Trials / Completed
CompletedNCT01322633
Risk of Cancer Among Pantoprazole Users
Long-Term Prospective Observational Study of the Risk of Cancer Among Pantoprazole Users
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 61,864 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective is to assess whether the risk of gastric cancer is increased in pantoprazole users compared to users of other proton pump inhibitors.
Detailed description
All subjects who met the inclusion criteria were included in the study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Does not apply | This is a non-interventional study, therefore the intervention type / name do not apply. |
| OTHER | Does not apply | This is a non-interventional study, therefore the intervention type / name do not apply. |
Timeline
- Start date
- 2004-07-01
- Primary completion
- 2013-03-01
- Completion
- 2013-03-01
- First posted
- 2011-03-24
- Last updated
- 2014-02-20
- Results posted
- 2014-02-20
Source: ClinicalTrials.gov record NCT01322633. Inclusion in this directory is not an endorsement.